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OBJECTIVES: To determine the effect of panretinal photocoagulation (PRP) on the peripapillary retinal nerve
fiber layer (RNFL) in nonglaucomatous patients with proliferative diabetic retinopathy (PDR).
METHODS: This is a prospective, single center, observational study. Thirty-eight eyes of 26 diabetic patients
underwent PRP for proliferative diabetic retinopathy. Peripapillary RNFL thickness was measured using scanning
laser polarimetry (SLP) with variable corneal compensation (GDx VCC; by Carl Zeiss Meditec, Dublin, CA) and
spectral-domain optical coherence tomography (OCT) (Heidelberg Spectralis, Carlsbad, USA) at baseline and
12 months after PRP was performed.
RESULTS: Thirty-eight eyes of 26 patients (15 female) with a mean age of 53.7 years (range 26 to 74 years) were
recruited. No significant difference was found among all RNFL thickness parameters tested by GDx VCC software
(p=0.952, 0.464 and 0.541 for temporal-superior-nasal-inferior-temporal (TSNIT) average, superior average,
inferior average, respectively). The nerve fiber indicator (NFI) had a nonsignificant increase (p=0.354). The OCT
results showed that the average RNFL thickness (360o measurement) decreased nonsignificantly from 97.2 mm to
96.0 mm at 1 year post-PRP (p=0.469). There was no significant difference when separately analyzing all the
peripapillary sectors (nasal superior, temporal superior, temporal, temporal inferior, nasal inferior and nasal
thickness).
CONCLUSION: Our results suggest that PRP, as performed in our study, does not cause significant changes in
peripapillary RNFL in diabetic PDR patients after one year of follow-up.
KEYWORDS: Panretinal Photocoagulation; Peripapillary Retinal Nerve Fiber Layer; Scanning Laser Polarimetry;
Diabetic Retinopathy; Optical Coherence Tomography.
’ INTRODUCTION
Diabetic retinopathy (DR) is one of the most significant
ocular complications related to diabetes mellitus (DM) and is
one of the main causes of blindness (1). DM is also an impor-
tant risk factor for chronic open angle glaucoma, and both
diseases often coexist.
In cases of proliferative diabetic retinopathy (PDR), pan-
retinal photocoagulation (PRP) is still considered the first-
line treatment. Although PRP reduces the risk of severe
vision loss (2), it has been shown that laser energy can cause
destruction to all layers of the retina, including ganglion cells
and the retinal nerve fiber layer (RNFL), and therefore
generate visual field defects similar to that observed in glau-
comatous damage (3). In such cases, visual field testing can
be less helpful in evaluating glaucomatous damage.
With the development of clinically available imaging
technology, previous studies showed that diabetic patients,
with or without retinopathy, present thinner RNFL thickness
than the normal population (4-6). Moreover, it has been sug-
gested that ganglion cell loss secondary to PRP and ascen-
ding RNFL atrophy can change the optic disc appearance
and topography (7).
Patients with glaucoma are traditionally managed by
intraocular pressure (IOP) monitoring, assessing the struc-
ture of the optic disc and RNFL (through retinography and
stereoscopic disc photographs), and functional evaluation
using achromatic perimetry. With advancements in techno-
logy, serial measurements of RNFL thickness are routinely
used to follow patients with glaucoma or suspected glaucoma
because a decrease in RNFL thickness may indicate disease
progression (8,9). Currently, quantitative and qualitative
evaluation of RNFL can be performed by scanning laserDOI: 10.6061/clinics/2019/e1163
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polarimetry (SLP) and optical coherence tomography (OCT),
aiding in the early detection of disease progression.
Previous studies have reported conflicting results of RNFL
and optic disc topographic measurements after PRP treat-
ment in diabetic patients (10-13). The current study investi-
gated changes in RNFL thickness acquired using different
image methods in diabetic patients after PRP.
’ MATERIALS AND METHODS
This prospective observational cohort study enrolled
patients from the retina service of the Ophthalmology Divi-
sion of the University of Sao Paulo Medical School. The
study protocol was approved by the local ethics committee
and adhered to the tenets of the Declaration of Helsinki.
Informed consent was obtained from all subjects.
The inclusion criteria for the study were as follows: diag-
nosis of PDR (due to type 1 or 2 DM), intraocular pressure
o18 mmHg, nonglaucomatous optic disc characteristics at
fundus examination, vertical cup-to-disc (C/D) ratio o0.7
and absence of media opacities. Subjects with a previous diag-
nosis or family history of glaucoma, any coexisting neu-
roophthalmic disease, uveitis, retinal vascular occlusion, optic
disc neovascularization, diabetic macular edema (DME),
corneal opacity or previous laser photocoagulation treat-
ment were excluded from the study. Subjects with optic disk
neovascularization were excluded due to the possible inter-
ference of the new vessels with the acquired images needed
per protocol; patients with DME were excluded to avoid any
interference of anti-VEGF intravitreal injections (indicated in
most such cases) with the trial results.
All participants underwent complete ophthalmological
examination at baseline, including best-corrected visual
acuity (BCVA) with Snellen charts, Goldmann applanation
tonometry, slit lamp biomicroscopy of anterior and fundus
segments using a 78D lens (Volk, Mentor, OH, USA), and
indirect binocular ophthalmoscopy. The RNFL of all patients
was imaged by SLP and spectral-domain OCT at baseline
and one year after the last laser treatment.
SLP is an imaging technology based on the principle that
polarized light suffers a measurable shift (known as retar-
dation) when it passes through the birefringent RNFL, and
this shift is linearly related to the nerve fiber layer thickness
(14). According to well-established methods, the peripapil-
lary RNFL of all enrolled patients was assessed using SLP by
GDx access in variable corneal compensator (VCC) mode
(software version 5.5.1: Zeiss-Humphrey Systems, Dublin,
California, USA). As previously described, GDx VCC auto-
matically compensates for corneal birefringence (15). For
consecutive exams, the software saves the acquisition posi-
tion around the optic disk, which enables consecutive exams
to be performed at the same anatomical location.
In the current study, the following parameters contained at
the standard printout of the GDx VCC instrument were
analyzed: superior average, inferior average, TSNIT (360o
RNFL thickness measured at the automatically defined 3.2-
mm-diameter calculation circle: T, temporal sector; S, super-
ior sector; N, nasal sector; I, inferior sector) average, TSNIT
standard deviation, and the nerve fiber indicator (NFI). The
NFI is calculated through an algorithm based on several RNFL
measures and assigns a number from 0 to 100 to each eye.
According to the manufacturer, higher NFI values corres-
pond to a greater likelihood that the patient has glaucoma (16).
Figure 1 is an example of a printout of the RNFL analysis
obtained from a study eye using the GDx VCC software.
RNFL thickness was also measured using Spectralis
spectral-domain optical coherence tomography (SD-OCT,
software version 6.3.4; Heidelberg Engineering, Carlsbad,
California, USA), according to protocols previously used in
similar studies (17-19). A high-resolution protocol was used,
and images were acquired by a single operator. The enrolled
patients were asked to look at the internal fixation target, and
a scan with a circle diameter of 3.45 mm was centered on the
optic disc. To be accepted, images had to have a signal
strength415 dB, be well centered and have accurate segmen-
tation. Follow-up mode was used to guarantee that the same
position of the first scan circle was imaged in subsequent
acquisitions. For this study, the following RNFL parameters,
which are available in the standard software evaluation as
shown in Figure 2, were evaluated: average RNFL, nasal
superior, temporal superior, temporal, temporal inferior, nasal
inferior and nasal thickness.
PRP treatment was carried out with a single spot green
laser (Purepoints laser system, 532 nm wavelength, Alcon,
Fort Worth, TX, USA). At least 1,500 peripheral laser photo-
coagulation burns were performed. The laser parameters
used were a spot size of 250 mm, a pulse duration of 0.2 s
and a sufficient power to cause moderate intensity burns
following Early Treatment Diabetic Retinopathy Research
Study (ETDRS) guidelines. PRP was carried out in 3 sessions,
each session was 1 week apart. All patients were submitted
to a complete ophthalmologic exam after 6 weeks to evaluate
disease status and the need for further laser sessions.
Figure 3 exemplifies the pattern of laser photocoagulation
Figure 1 - Printout of the retinal nerve fiber layer (RNFL) analysis
with scanning laser polarimetry (SLP) with variable corneal
compensation (GDx VCC).
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applied in the study and the distance between the laser burns
and the optic disc margins.
Statistical analyses were performed using commer-
cially available computer software (SPSS, ver. 23.0; SPSS,
Chicago, USA). Normality was tested using the one-sample
Kolmogorov-Smirnov test. The Wilcoxon signed ranks test
was used to compare the RNFL parameters measured by
SLP and OCT parameters before and after laser treat-
ment. The statistical significance level was considered at
po0.05.
Figure 2 - Example of the Spectralis spectral-domain OCT displaying the RNFL thickness parameters according to comparisons with a
normative database population.
Figure 3 - Retinography (montage) of the posterior pole and mid periphery exemplifying the pattern of laser photocoagulation
performed in the study.
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’ RESULTS
This study included 42 eyes of 30 patients. Four eyes of
4 patients were excluded during the follow-up visits: one
patient developed preretinal membranes causing tractional
detachment and another developed vitreous hemorrhage in
the eye; both of these patients were submitted to pars plana
vitrectomy; another two eyes developed macular edema and
were treated with intravitreal anti-VEGF (vascular endothe-
lial growth factor) injections. Thirty-eight eyes of 26 indivi-
duals (15 female, 11 male) completed the one-year follow-up.
The mean age was 53.7 years, ranging from 26 to 74 years.
No significant difference was found among all the RNFL
thickness parameters tested by GDx VCC software (p=
0.952, 0.464 and 0.541 for temporal-superior-nasal-inferior-
temporal (TSNIT) average, superior average, inferior aver-
age, respectively). The NFI increased from 26.9±10.1 to
28.4±10.5, but the difference was not statistically significant
(p=0.354). The data are summarized in Table 1.
The OCT results are presented in Table 2. The average
RNFL thickness (360o measurement) decreased nonsignifi-
cantly from 97.2 mm to 96.0 mm at 1-year post-PRP (p=0.469).
When all the peripapillary sectors were analyzed separa-
tely (nasal superior, temporal superior, temporal, temporal
inferior, nasal inferior and nasal), an RNFL thickness reduc-
tion was also found but did not reach statistical significance
(p=0.410, 0.413, 0.565, 0.168, 0.931 and 0.121, respectively).
’ DISCUSSION
Laser photocoagulation decreases the risk of blindness in
PDR patients, and despite the evidence of efficacy of antian-
giogenic drugs, it is still considered the standard of care for
the management of proliferative disease, according to The
American Academy of Ophthalmology’s Preferred Practice
Pattern for Diabetic Retinopathy (20), which valorizes the
findings of the Diabetic Retinopathy Study (2) and the ETDRS
(21) (level 1 evidence). While most visual complications in
patients with PDR are related to retinal damage, it is not
uncommon for patients to have glaucoma-associated visual
loss either because of disease unrelated to diabetes or because
of intraocular pressure elevation from PRP or treatment
modalities such as corticosteroid injection. Therefore, while
the causal relationship between DM and glaucoma in many
cases remains unclear (22), the diagnosis of glaucoma in
patients who have advanced DR can be challenging, parti-
cularly when submitted to PRP, as laser treatment can cause
visual field changes that may mimic the field loss observed in
glaucomatous patients.
Even in cases without DR, diabetes can cause alterations in
the retinal structure. RNFL thickness measurements have
shown that diabetic patients even without clinically evident
retinopathy and those with nonproliferative disease have
thinner nerve fiber layer thickness than controls without
diabetes (4-6,23). This finding might be explained by the
upregulation of enhanced apoptosis promoting factors
causing early death of ganglion cells in diabetic patients (24).
In the current study, two different acquisition technologies
were used to analyze the effects of PRP on RNFL. As both
OCT and GDx showed no statistical change in RNFL thick-
ness, we believe the use of different technologies reinforces
our findings. Considering that the circular scan used for OCT
acquisition is larger than the scan used on GDx (3.4 versus
3.2 mm), one would expect larger numerical OCT measure-
ments for GDx than OCT. However, numerical data or maps
from the two different technologies should not be directly
compared, as GDx and OCT technologies are based on two
different optical properties. While GDx uses changes in the
polarization properties of light to determine thickness, OCT
is based on the interference of light that passes through the
tissue of the eye with a reference optical path to determine
thickness at each point and construct an image. Therefore,
these two technologies do not allow direct comparison, but
there are numerous publications that demonstrate their
importance in diagnosing glaucoma and monitoring RNFL
thickness (4-6,8-11,16,17,19).
Some studies have shown conflicting evidence regarding
the effect of PRP on RNFL peripapillary thickness. Ritenour
et al. (11) observed an increase in RNFL thickness up to
6 months after laser photocoagulation in their study using
SLP. Similar findings were reported by Maia OO et al. (10)
using time-domain OCT. Using the same OCT technology,
Lim et al. (12) compared healthy eyes with PDR eyes under-
going PRP and noticed that the group treated with laser
presented a thinner RNFL thickness than the control group,
Table 2 - Average retinal nerve fiber layer (RNFL) thickness
measures by spectral-domain optical coherence tomography
before and 1 year after panretinal photocoagulation (n=38).
RNFL Thickness Pretreatment Posttreatment p*
Mean (lm)±SD Mean (lm)±SD
Global 97.2±13.4 96.0±12.3 0.469
Nasal Superior 106.9±23.2 105.0±19.8 0.410
Temporal Superior 133.3±20.6 132.0±18.9 0.413
Temporal 75.4±12.6 74.3±12.6 0.565
Temporal Inferior 140.1±24.1 139.0±22.9 0.168
Nasal Inferior 108.0±26.8 104.2±21.7 0.931
Nasal 70.0±12.8 68.9±15.3 0.121
RNFL, retinal nerve fiber layer; SD, standard deviation.
*Wilcoxon signed rank-test.
Table 1 - Comparison of scanning laser polarimetry (SLP) with variable corneal compensation (GDx VCC) parameters before and after
panretinal photocoagulation (n=38).
Parameters Pretreatment Posttreatment p*
Mean±SD Range Mean±SD Range
TSNIT Avg (mm) 47.9±5.7 46.0–49.7 47.7±4.9 46.0–49.3 0.952
Superior Avg (mm) 59.5±8.5 56.7–62.3 58.8±7.4 56.3–61.2 0.464
Inferior Avg (mm) 58.4±9.3 55.3–61.4 58.9±8.8 56.0–61.8 0.541
TSNIT SD (mm) 22.4±3.8 21.2–23.7 22.4±4.0 21.1–23.8 0.743
NFI 26.9±10.1 23.5–30.2 28.4±10.5 25.0–31.9 0.354
SD, standard deviation; TSNIT, temporal-superior-nasal-inferior-temporal; NFI, nerve fiber indicator. Avg, Average.
*Wilcoxon signed rank-test.
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although the authors did not compare pre- and post-laser
RNFL thickness in the same group. On the other hand, using
the same technology as in the above-mentioned studies, Kim
and Cho (13) did not find a statistically significant decrease
in the RNFL thickness of the group treated with PRP com-
pared with the untreated control group. Lee et al. (25) perfor-
med one of the few prospective studies on this subject using
time-domain OCT. They found that RNFL thickness tends to
increase in the first 6 months and then decrease 2 years after
PRP compared with pretreatment peripapillary RNFL thick-
ness. Therefore, a short-term increase in RNFL thickness has
been consistently reported in most studies (10,13,25), but the
long-term effect of laser photocoagulation on RNFL remains
controversial.
In this study, two different technologies, SLP and OCT-SD,
were employed to measure the RNFL peripapillary thick-
ness, and our results showed no statistically significant differ-
ence for either method between one year after conventional
PRP and baseline before starting treatment. These results are
similar to those found in another prospective trial that used
laser scan pattern (PASCAL) photocoagulation, which is a new
form of multispot laser treatment with shorter pulse duration
(and consequently, is more restricted to retinal damage) than
conventional single spot PRP (26). One hypothesis to explain
the inconsistent findings in the literature related to RNFL
changes after PRP is that different laser delivery may cause
different degrees of inner retinal changes. While in our study
a spot size of 250 mm was used, a larger spot size or laser
intensity may be related to greater inner retinal damage and,
therefore, more reduction in RNFL thickness due to retro-
grade axonal loss.
A recently published subanalysis of protocol S, a multi-
centric and randomized clinical trial that compared PRP or
anti-VEGF for PDR cases, evaluated the effect of PRP and
ranibizumab intravitreal injections on RNFL peripapillary
thickness and found that after 2 years of follow-up, eyes
treated with intravitreal anti-VEGF injections had greater
RNFL thinning than eyes submitted to PRP. Patients who
were treated with PRP and did not have baseline DME had,
on average, no change in RNFL thickness after one year of
follow-up and an average decrease of less than 5 mm after
2 years (28). These data confirm that PRP, as performed in
this study or in protocol S, has minor effects on RNFL
thickness changes after one year. Patients receiving anti-
VEGF injections had a different response than patients
treated with PRP in protocol S, with an average loss of more
than 10 mm in RNFL thickness after 2 years. The possible
interference of DME and intravitreal anti-VEGF on RNFL
thickness parameters led us to restrict our eligibility criteria
for PDR patients without clinically significant macular
edema. Moreover, two eyes that developed significant
DME during the follow-up period were excluded from the
analysis and were treated according to the current best
clinical practices with anti-VEGF intravitreal injections.
A limitation of our study is the relatively small number of
patients recruited. However, our sample is similar to other
prospective interventional studies (7), and we adopted rigid
inclusion criteria that excluded patients with optic disk
neovascularization and/or baseline DME to achieve good
internal validation. The presence of disk neovascularization
does not allow an adequate analysis of the anatomy of the
optic disc and peripapillary region by the GDx and OCT
because fibrovascular tissue can obscure the edges of the
optic cup and impair measurements of RNFL thickness (7).
Moreover, DME is frequently present when PDR is detected
in diabetic patients and often requires additional treatment
with intravitreal anti-VEGF injections, which could some-
how interfere with the parameters analyzed in our study. For
proper documentation of the RNFL and to avoid the bias of
anti-VEGF injections, only PDR cases without disc neovas-
cularization and without macular edema were eligible for
this particular study. We know from the diabetic retinopathy
study (DRS) that only 40% of PDR cases do not present with
disc neovascularization (2). The DRCR net protocol S (27),
a multicentric and randomized clinical trial that compared
PRP or anti-VEGF for PDR cases, reported that approxi-
mately 22% of participants with PDR had DME at baseline.
Therefore, most PDR patients who presented at our center
were not eligible for this study.
In conclusion, we prospectively followed PDR patients
submitted to laser PRP. Data from our study show that PRP
did not cause significant changes in RNFL peripapillary
thickness after 1 year of treatment. Therefore, moderate
intensity laser, as employed in this trial, can be used in PDR
patients without causing significant changes in RNFL thick-
ness, thus avoiding potential diagnostic confusion with glau-
coma or its progression in such a population.
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